Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

US Patent 11926670 · Granted Mar 12, 2024

Estimated economic value: $178,363,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Devices and methods for overfilling drug containers2025
VEGF antagonist formulations suitable for intravitreal administration2025
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodie2024
Process for reducing subvisible particles in a pharmaceutical formulation2024
Process for reducing subvisible particles in a pharmaceutical formulation2024
Target residual moisture content for lyophilized drug product2024
Methods of reducing particle formation and compositions formed thereby2024
Devices and methods for overfilling drug containers2024
Citrate buffered VEGF antagonist formulations2023
VEGF antagonist formulations suitable for intravitreal administration2023
Target residual moisture content for lyophilized drug product2023
Stabilized formulations containing anti-PCSK9 antibodies2023